Trader Note — 8726 total
ORCL has steadied slightly from last week's low, closing Tuesday at $119.96, yet the short position that exploded 30% in a single week has barely retreated — and the stock remains 42% below where it traded the day…
Everforth, Inc. delivered exactly the kind of violent earnings reaction its history warned about, and the stock's 27% weekly surge has landed it in a genuinely interesting position: short interest is quietly climbing…
Omega Healthcare Investors enters Wednesday with the July 29 earnings print just cleared, options traders at their most bullish in a year, and short sellers unwinding positions into a stock that has re-rated sharply…
NWPX Infrastructure heads into Wednesday's earnings report with short sellers at their most aggressive in months — and the stock already down sharply from its highs. The short interest story here is genuinely notable.…
NPK International heads into its Q2 earnings print on July 30 with the stock down 17% over the past month, insiders having sold heavily near the highs, and options traders unusually bullish — a combination of signals…
National Fuel Gas Company reports fiscal Q3 results on July 30 with a story that splits cleanly in two: options traders are the most bullish they've been all year, while short sellers are sitting tight rather than…
Napco Security Technologies heads into its August 24 earnings date with short interest quietly rebuilding over the past week even as the stock grinds modestly higher — a small but pointed divergence worth watching. The…
NBT Bancorp reported Q2 results on July 28 and moved higher, leaving the short sellers who had been aggressively building positions ahead of the print nursing losses. The earnings reaction settles what was a genuinely…
Myriad Genetics arrives at its July 30 earnings release down 10% on the week and carrying the memory of a 17% one-day collapse after its last quarterly print in May. The stock closed at $5.32 on Tuesday, extending a…
Modine Manufacturing closed Tuesday at $208.06, down nearly 10% on the day and 16% on the week, as the fiscal Q1 print landed and the market delivered its verdict. The earnings reaction is the story this week. The…
Mid-America Apartment Communities reported Q2 earnings on July 29 and the market liked what it heard — the stock closed at $135.64 on July 28, up 1.6% on the day and 2.6% on the week, outperforming most of its…
Meritage Homes reports Q2 results tomorrow against a backdrop that captures the homebuilder sector's split personality right now: peers rallying hard into earnings, Goldman lifting its target, yet the stock sitting 14%…
McGrath RentCorp heads into the back half of summer with options traders notably less defensive than they were a month ago — even as the stock itself drifts a little lower. The clearest shift this week is in options…
Markel Group heads into its Q2 earnings release on July 30 with the stock near a one-month high, options positioning still tilted defensive, and a recent earnings track record that has consistently punished bulls. The…
MGIC Investment Corporation reports Q2 results on July 30 with a notable divergence at its core: the stock has rallied 5% on the week and nearly 10% over the past month, yet virtually everyone with direct knowledge of…
M&T Bank enters the back half of summer with short sellers in retreat and options markets flashing their most bullish signal in months — a combination that reinforces the stock's 6.5% climb over the past month to…
Lam Research reported Q4 2026 results on July 29 and the stock's post-earnings reaction has extended the damage from a bruising month, with the defining tension unchanged: the analyst community remains firmly bullish…
LSB Industries heads into its Q2 earnings print — scheduled for July 30 — with options traders expressing the most bullish positioning seen in a year, even as short sellers quietly rebuild their bets. The clearest…
KSS enters the final stretch before its August 27 earnings with short interest entrenched near 27% of float — one of the heaviest short positions in US retail — while the stock quietly posts a 5.3% weekly gain to…
Johnson & Johnson has pushed further into recovery territory, adding 6.4% on the week to close at $266.73 — now sitting above several analyst price targets and approaching the upper end of the Street's consensus…
